Xilio Therapeutics, Inc. (XLO) Corporate Subsidiaries
Xilio Therapeutics, Inc. (XLO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XLO
CIK: 1840233
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerAshden Haase
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412466 | View SEC Doc Filr Page |
| 3 | 2026-10-02 | 2026-09-28 | 3 | 0001193125-26-412453 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096755 | View SEC Doc Filr Page |
| S-8 | 2026-08-12 | — | S-8 | 0001193125-26-345762 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345759 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345753 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269399 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269400 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269401 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269398 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269397 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269396 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269395 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | 8-K | 0001193125-26-269358 | View SEC Doc Filr Page |
| EFFECT | 2026-05-29 | — | EFFECT Filing | 9999999995-26-001811 | View SEC Doc Filr Page |
| CORRESP | 2026-05-27 | — | CORRESP Filing | 0001193125-26-242232 | View SEC Doc Filr Page |
| S-3/A | 2026-05-27 | — | S-3/A | 0001193125-26-242204 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-18 | — | UPLOAD Filing | 0000000000-26-005065 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000947871-26-000552 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-226925 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003488 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000919574-26-003213 | View SEC Doc Filr Page |
| S-3 | 2026-05-12 | — | S-3 | 0001193125-26-218212 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-218200 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218194 | View SEC Doc Filr Page |